Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 7Recruiting 6Completed 5Withdrawn 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lung Neoplasms 3Ovarian Neoplasms 2Mesothelioma, Malignant 2Fallopian Tube Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pelvic Neoplasms 1Oropharyngeal Neoplasms 1Nausea 1Nasopharyngeal Carcinoma 1Mesothelioma 1Lymphoid Interstitial Pneumonia 1Liposarcoma 1Extensive Stage Lung Small Cell Carcinoma 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Endometrioid 1Brenner Tumor 1

Interventions

pembrolizumab 40Cisplatin 32Radiotherapy 22Cetuximab 22Radiotherapy, Intensity-Modulated 15Docetaxel 12Nivolumab 11Paclitaxel 10Fluorouracil 10Carboplatin 8Radiosurgery 6epacadostat 5Radiation 5spartalizumab 4avelumab 4Surgical Procedures, Operative 4Radiotherapy, Conformal 4Immunoglobulin G 4Biopsy 4ribociclib 3durvalumab 3bempegaldesleukin 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Everolimus 3Erlotinib Hydrochloride 3Disulfides 3Cyclophosphamide 3Albumin-Bound Paclitaxel 3utomilumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Squamous Cell Carcinoma of Head and Neck × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02196168 2017-05-03

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 9 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡